KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Pacific Biosciences Of California (PACB) Shares Issued (2016 - 2025)

Pacific Biosciences Of California has reported Shares Issued over the past 16 years, most recently at $1.5 million for Q3 2025.

  • Quarterly results put Shares Issued at $1.5 million for Q3 2025, up 80.91% from a year ago — trailing twelve months through Dec 2025 was $3.4 million (down 55.5% YoY), and the annual figure for FY2025 was $3.4 million, down 55.5%.
  • Shares Issued for Q3 2025 was $1.5 million at Pacific Biosciences Of California, down from $2.0 million in the prior quarter.
  • Over the last five years, Shares Issued for PACB hit a ceiling of $300.0 million in Q3 2021 and a floor of -$174.8 million in Q3 2023.
  • Median Shares Issued over the past 5 years was $4.9 million (2021), compared with a mean of $44.9 million.
  • Biggest five-year swings in Shares Issued: skyrocketed 11127.64% in 2021 and later plummeted 96.36% in 2024.
  • Pacific Biosciences Of California's Shares Issued stood at $1.7 million in 2021, then skyrocketed by 566.47% to $11.2 million in 2022, then skyrocketed by 1456.7% to $174.8 million in 2023, then plummeted by 99.54% to $812000.0 in 2024, then soared by 80.91% to $1.5 million in 2025.
  • The last three reported values for Shares Issued were $1.5 million (Q3 2025), $2.0 million (Q1 2025), and $812000.0 (Q3 2024) per Business Quant data.